期刊文献+

2型糖尿病合并血管并发症患者一氧化氮和内皮素水平评价 被引量:4

Evaluation of levels of nitric oxide and endothelin in type 2 diabetes patients with angiopathy
原文传递
导出
摘要 目的探讨合并血管并发症的2型糖尿病患者血清一氧化氮(nitric oxide,NO)和内皮素(endothelin,ET)水平的变化,并分析各危险因素与两者之间的关系。方法入选2型糖尿病患者98例,根据分组条件分为糖尿病合并血管并发症组(A组,49例)和糖尿病无血管并发症组(B组,49例),同期选择年龄、体质指数相匹配的健康对照44例(C组)。所有受试者记录身高、体质量、血压、病程,抽血检测空腹血糖(fasting blood-glucose,FBG)、糖化血红蛋白(hemoglobin A1c,Hb A1c)、血脂各项指标,以及血清NO和ET-1水平。结果与C组比较,A组及B组的NO水平均显著降低[(43.87±12.05)和(53.29±11.75)μmol/L vs(66.08±16.48)μmol/L,P<0.01],而ET-1水平显著升高[(100.25±20.34)和(77.55±14.84)ng/L vs(53.62±8.40)ng/L,P<0.01]。A组NO水平显著低于B组[(43.87±12.05)vs(53.29±11.75)μmol/L,P<0.01],而ET-1水平显著高于B组[(100.25±20.34)vs(77.55±14.84)ng/L,P<0.01]。在糖尿病两组之间,收缩压、舒张压、Hb A1c及病程,A组明显高于B组(P<0.01)。相关分析显示,舒张压、收缩压、空腹血糖、Hb A1c与NO之间存在负相关;HDL-C与NO之间存在正相关。HDL-C与ET-1存在负相关;收缩压、LDL-C、血尿酸、空腹血糖、Hb A1c与ET-1之间存在正相关。结论糖尿病患者血清NO和ET水平明显异常,存在血管内皮功能损伤;有血管并发症者损伤更严重,且与血糖、血压、血脂的控制水平具有相关性。 Objective To investigate the changes in serum levels of nitric oxide( NO) and endothelin( ET) in type 2diabetes patients with vascular complications,and to analyze the relationship between these levels and risk factors. Method We selected 98 cases of type 2 diabetes patients. Based on the grouping criteria,the patients were divided into diabetic patients with vascular complications( group A,49 cases) and those without( group B,49 cases). In addition,44 age-and body mass index-matched healthy cases were selected for control( group C). Height,weight,blood pressure,duration of diabetes,fasting blood glucose,hemoglobin A1c( Hb A1c),blood lipids,and serum levels of NO and ET-1 of all the patients were recorded. Results The NO levels of the two groups with diabetes mellitus were significantly lower than in group C[( 43. 87 ± 12. 05) and( 53. 29 ± 11. 75) μmol / L versus( 66. 08 ± 16. 48) μmol / L,P〈0. 01 ],while the ET-1levels of the two groups with diabetes mellitus were significantly higher [( 100. 25 ± 20. 34) and( 77. 55 ± 14. 84) versus( 53. 62 ± 8.40) ng/L,P〈0.01]than those of the group C. The NO levels of group A were significantly lower than in group B[( 43.87 ±12.05) versus( 53. 29 ± 11. 75) μmol/L,P〈0. 01]. Moreover,the ET-1 levels of the group A were significantly higher than in group B [( 100. 25 ± 20. 34) versus( 77. 55 ± 14. 84) ng / L,P〈0. 01]. Between the two diabetic groups,group A showed significantly higher systolic blood pressure( SBP),diastolic blood pressure( DBP),Hb A1 c,and course than group B( P〈0. 01). Correlation analysis showed a negative correlation between SBP,DBP,fasting blood glucose,Hb A1 c,and NO a positive correlation between high-density lipoprotein cholesterol( HDL-C) and NO, a negative correlation between HDL-C and ET-1,and a positive correlation between SBP,LDL-C,uric acid,fasting blood glucose,Hb A1 c,and ET-1. Conclusion The serum levels of NO and ET-1 in diabetic patients are evidently abnormal. Vascular endothelium injury will become more serious in patients with complications. Therefore,the serum levels of NO and ET-1 in diabetic patients are correlated with control of blood glucose,blood pressure,and blood lipid levels.
出处 《军事医学》 CAS CSCD 北大核心 2015年第7期546-549,共4页 Military Medical Sciences
基金 首都医学科研发展基金资助项目(2009-12-2010-2013-11)
关键词 2型糖尿病 血管并发症 一氧化氮 内皮素 type 2 diabetes mellitus vascular complications nitric oxide endothelin
  • 相关文献

参考文献13

  • 1Bobik A, Grooms A, Millar JA, et al. Growth factor activity of endothelin on vasacular smooth muscle [J]. Am J Physiol, 1990, 258 (3 Pt I) : C408 - C415.
  • 2Wu Z, Qian X, Cai D, et al. Long-term oral administration of Larginine enhances endothelium-dependent vasorelaxation and inhibits neointimal thickening after endothelial denudation in rats [J]. Clin Med J, 1996, 109 ( 8) :592 - 598.
  • 3Moncada S, Palmer RMJ, Riggs EA. Nitric oxide: physiology , pathophysiology and pharmacology [J]. Pharrnacol Rev, 1991 ,43 (2) :109 -142.
  • 4Nishikawa T, Edeistein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage [J]. Nature,2000 ,404(6779) :787 -790.
  • 5Van Etten RW,de Koning EJ,Verhaar MC, et al, Impaired NOdependent vasodilation in patients with type II ( non-insulin-dependent) diabetes mellitus is restored by acute administration of folate[J]. Diabetologia,2002,45(7) :1004 -1010.
  • 6Wascher TC, Graier WF, Bahadori B. Time course of endothelial dysfunction in diabetes mellitus [J]. Circulation, 1994 , 90 ( 2 ) : 1109 -1110.
  • 7路文盛,师布朵,黄群,林园梅,杨川,黄勤.不同血糖情况下的血管内皮功能与PGC-1α对糖尿病大血管的保护作用[J].中华内分泌代谢杂志,2013,29(6):479-483. 被引量:9
  • 8郭立新,汪恕萍,钱庆文.内皮素转换酶内皮素系统与2型糖尿病大血管病变关系的研究[J].中华内分泌代谢杂志,2002,18(1):20-23. 被引量:26
  • 9胡蜀红,张建华,蔡仕林.糖尿病视网膜病变与血浆内皮素的关系[J].临床荟萃,2003,18(12):677-678. 被引量:12
  • 10Hermann F, Enseleit F, Spieker LE, et al, Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemiaj J], Thrombosis Res, 2009, 123(3) :460 -465.

二级参考文献29

  • 1周玲,黄友镐.糖尿病视网膜病变与血浆内皮素的相关研究[J].临床内科杂志,1995,12(6):33-33. 被引量:7
  • 2钟惠菊,郭丽娟.糖尿病视网膜病变者血浆内皮素水平及导明治疗后的变化[J].湖南医科大学学报,1997,22(1):56-58. 被引量:9
  • 3Maeno Y, Li Q, Park K, et al. Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3 K). J Bioi Chem, 2012, 287 :4518-4530.
  • 4Lockhart CJ, Agnew CE, McCann A, et al. Impaired flow-mediated dilatation response in uncomplicated Type 1 diabetes mellitus: influence of shear stress and microvascular reactivity. Clin Sci (Lond) , 2011 , 121: 129-139.
  • 5Hofmann MA, Schiekofer S, Kanitz M, et al. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care, 1998,21 :1310-1316.
  • 6Sodre FL, Paim BA, Urban A, et al. Reduction in generation of reactive oxygen species and endothelial dysfunction during postprandial state. Nutr Metab Cardiovasc Dis, 2011 ,21 :800-807.
  • 7Marsh N, Marsh A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol , 2000,27: 313-319.
  • 8Chen Z, Stamler JS. Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase. Trends Cardiovasc Med, 2006,16 :259-265.
  • 9Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med, 2007, 356: 1517-1526.
  • 10Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta, 2011 ,1813: 1269-1278.

共引文献43

同被引文献48

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部